TrialBone marrow transplantation2012

The anti-tumour activity of allogeneic cytokine-induced killer cells in patients who relapse after allogeneic transplant for haematological malignancies.

Y-C Linn et al.PubMed ↗Publisher ↗

No numbers read from the abstract.